Population of the HLA ligand database.
暂无分享,去创建一个
M. Sathiamurthy | W. Hildebrand | H. Hickman | K. Prilliman | M. F. Fernandez Vina | M Sathiamurthy | H D Hickman | J W Cavett | A Zahoor | K Prilliman | S Metcalf | M Fernandez Vina | W H Hildebrand | J. Cavett | A. Zahoor | S. Metcalf
[1] P. Parham,et al. Nature of polymorphism in HLA-A, -B, and -C molecules. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Rosenberg,et al. Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining Assays , 2001, Journal of Virology.
[3] R. Germain. Immunology: The ins and outs of antigen processing and presentations , 1986, Nature.
[4] Ilan Beer,et al. Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor‐specific antigens , 2002, European journal of immunology.
[5] Mark Lindsey,et al. Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501 , 1997, Immunogenetics.
[6] Hans-Georg Rammensee,et al. MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.
[7] J. Galán,et al. Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. , 2001, Vaccine.
[8] P. Parham,et al. Guilt by association: HLA-B27 and ankylosing spondylitis. , 1990, Immunology today.
[9] J. Altman,et al. Peptide-MHC Class I Tetrameric Complexes Display Exquisite Ligand Specificity1 , 2000, The Journal of Immunology.
[10] Mark Lindsey,et al. Complexity among constituents of the HLA-B*1501 peptide motif , 1998, Immunogenetics.
[11] F. Brodsky,et al. Human pathogen subversion of antigen presentation , 1999, Immunological reviews.
[12] V. Gnau,et al. Peptide motifs of HLA-A1,-A11,-A31, and-A33 molecules , 1994, Immunogenetics.
[13] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[14] C. Sylvester-Hvid,et al. Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds , 2001, European journal of immunology.
[15] J. Shabanowitz,et al. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. , 1998, Cancer research.
[16] C. Herberts,et al. A single naturally processed measles virus peptide fully dominates the HLA‐A*0201‐associated peptide display and is mutated at its anchor position in persistent viral strains , 2000, European journal of immunology.
[17] P. Cresswell,et al. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment , 1990, Nature.
[18] W. Hildebrand,et al. HLA-B15 peptide ligands are preferentially anchored at their C termini. , 1999, Journal of immunology.
[19] P. Parham,et al. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes , 1995, Current Biology.
[20] H. Rammensee,et al. Peptide motifs of closely related HLA class I molecules encompass substantial differences , 1992, European journal of immunology.
[21] P. Brossart,et al. Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method. , 1998, Cancer research.
[22] W. Pichler,et al. Perspectives: towards a peptide-based vaccine against hepatitis C virus. , 2001, Molecular immunology.
[23] Andrew J. McMichael,et al. Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.
[24] W. Hildebrand,et al. C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells. , 2000, Human immunology.
[25] R. Koup,et al. Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production. , 2001, Immunology letters.
[26] M. Owais,et al. Fusogenic potential of prokaryotic membrane lipids. , 2001 .
[27] K. Cao,et al. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. , 2001, Human immunology.
[28] D. Rognan,et al. Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. , 1999, Journal of medicinal chemistry.
[29] J. Sidney,et al. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. , 1994, Molecular immunology.
[30] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[31] D. Nixon,et al. Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm. , 2000, AIDS research and human retroviruses.
[32] R. Henderson,et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. , 1993, Journal of immunology.
[33] A Sette,et al. Definition of specific peptide motifs for four major HLA-A alleles. , 1994, Journal of immunology.
[34] A. Burny,et al. Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-A11-immunized individual. , 1994, AIDS research and human retroviruses.
[35] R. Henderson,et al. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. , 1993, Journal of immunology.
[36] Vladimir Brusic,et al. Prediction of promiscuous peptides that bind HLA class I molecules , 2002, Immunology and cell biology.